199 related articles for article (PubMed ID: 21741043)
1. Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI.
Peters BJ; Pett H; Klungel OH; Stricker BH; Psaty BM; Glazer NL; Wiggins KL; Bis JC; de Boer A; Maitland-van der Zee AH
Atherosclerosis; 2011 Aug; 217(2):458-64. PubMed ID: 21741043
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of statins in the reduction of the risk of myocardial infarction is modified by the GNB3 C825T variant.
Peters BJ; Maitland-van der Zee AH; Stricker BH; van Wieren-de Wijer DB; de Boer A; Kroon AA; de Leeuw PW; Schiffers P; Janssen RG; van Duijn CM; Klungel OH
Pharmacogenet Genomics; 2008 Jul; 18(7):631-6. PubMed ID: 18551043
[TBL] [Abstract][Full Text] [Related]
3. Interactions of several lipid-related gene polymorphisms and cigarette smoking on blood pressure levels.
Yin RX; Wu DF; Wu JZ; Cao XL; Aung LH; Miao L; Long XJ; Liu WY; Zhang L; Li M
Int J Biol Sci; 2012; 8(5):685-96. PubMed ID: 22606049
[TBL] [Abstract][Full Text] [Related]
4. Association of several lipid-related gene polymorphisms and blood pressure variation in the Bai Ku Yao population.
Yin RX; Wu JZ; Liu WY; Wu DF; Cao XL; Miao L; Htet Aung LH; Zhang L; Long XJ; Li M; Pan SL
Am J Hypertens; 2012 Aug; 25(8):927-36. PubMed ID: 22573014
[TBL] [Abstract][Full Text] [Related]
5. Variants of ADAMTS1 modify the effectiveness of statins in reducing the risk of myocardial infarction.
Peters BJ; Rodin AS; Klungel OH; Stricker BH; de Boer A; Maitland-van der Zee AH
Pharmacogenet Genomics; 2010 Dec; 20(12):766-74. PubMed ID: 21037509
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic interactions between ABCB1 and SLCO1B1 tagging SNPs and the effectiveness of statins in the prevention of myocardial infarction.
Peters BJ; Rodin AS; Klungel OH; van Duijn CM; Stricker BH; van't Slot R; de Boer A; Maitland-van der Zee AH
Pharmacogenomics; 2010 Aug; 11(8):1065-76. PubMed ID: 20712525
[TBL] [Abstract][Full Text] [Related]
7. Influence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects.
Anderson JM; Cerda A; Hirata MH; Rodrigues AC; Dorea EL; Bernik MM; Bertolami MC; Faludi AA; Hirata RD
J Clin Lipidol; 2014; 8(3):256-64. PubMed ID: 24793346
[TBL] [Abstract][Full Text] [Related]
8. Interactions of several genetic polymorphisms and alcohol consumption on blood pressure levels.
Yin RX; Aung LH; Long XJ; Yan TT; Cao XL; Huang F; Wu JZ; Yang DZ; Lin WX; Pan SL
Biofactors; 2015; 41(5):339-51. PubMed ID: 26354227
[TBL] [Abstract][Full Text] [Related]
9. AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trial.
Desai NR; Kohli P; Giugliano RP; O'Donoghue ML; Somaratne R; Zhou J; Hoffman EB; Huang F; Rogers WJ; Wasserman SM; Scott R; Sabatine MS
Circulation; 2013 Aug; 128(9):962-9. PubMed ID: 23884353
[TBL] [Abstract][Full Text] [Related]
10. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat diet.
Song G; Liu J; Zhao Z; Yu Y; Tian H; Yao S; Li G; Qin S
Lipids Health Dis; 2011 Jan; 10():8. PubMed ID: 21241519
[TBL] [Abstract][Full Text] [Related]
12. Common sequence variants in pharmacodynamic and pharmacokinetic pathway-related genes conferring LDL cholesterol response to statins.
Chien KL; Wang KC; Chen YC; Chao CL; Hsu HC; Chen MF; Chen WJ
Pharmacogenomics; 2010 Mar; 11(3):309-17. PubMed ID: 20235787
[TBL] [Abstract][Full Text] [Related]
13. A case of ezetimibe-effective hypercholesterolemia with a novel heterozygous variant in ABCG5.
Nakano Y; Komiya C; Shimizu H; Mishima H; Shiba K; Tsujimoto K; Ikeda K; Kashimada K; Dateki S; Yoshiura KI; Ogawa Y; Yamada T
Endocr J; 2020 Nov; 67(11):1099-1105. PubMed ID: 32641618
[TBL] [Abstract][Full Text] [Related]
14. KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly.
Akao H; Polisecki E; Kajinami K; Trompet S; Robertson M; Ford I; Jukema JW; de Craen AJ; Westendorp RG; Shepherd J; Packard C; Buckley BM; Schaefer EJ
Atherosclerosis; 2012 Feb; 220(2):456-62. PubMed ID: 22192511
[TBL] [Abstract][Full Text] [Related]
15. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
Sahebkar A; Watts GF
Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
[TBL] [Abstract][Full Text] [Related]
16. No association between CYP3A4*22 and statin effectiveness in reducing the risk for myocardial infarction.
Leusink M; de Keyser CE; Onland-Moret NC; Hofman A; Visser LE; Stricker BH; de Bakker PI; de Boer A; van Schaik RH; Maitland-van der Zee AH
Pharmacogenomics; 2014 Aug; 15(11):1471-7. PubMed ID: 25303298
[TBL] [Abstract][Full Text] [Related]
17. LDL-c-linked SNPs are associated with LDL-c and myocardial infarction despite lipid-lowering therapy in patients with established vascular disease.
van de Woestijne AP; van der Graaf Y; de Bakker PI; Asselbergs FW; de Borst GJ; Algra A; Spiering W; Visseren FL;
Eur J Clin Invest; 2014 Feb; 44(2):184-91. PubMed ID: 24251769
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol levels and the association of statins with in-hospital mortality of myocardial infarction patients insights from a Chilean registry of myocardial infarction.
Martínez G; Rigotti A; Acevedo M; Navarrete C; Rosales J; Giugliano RP; Corbalán R
Clin Cardiol; 2013 Jun; 36(6):305-11. PubMed ID: 23494544
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly.
Akao H; Polisecki E; Kajinami K; Trompet S; Robertson M; Ford I; Jukema JW; de Craen AJ; Westendorp RG; Shepherd J; Packard C; Buckley BM; Schaefer EJ
Atherosclerosis; 2012 Feb; 220(2):413-7. PubMed ID: 22189199
[TBL] [Abstract][Full Text] [Related]
20. [Cholesterol associated to low density lipoproteins (LDL) and vascular risk reduction. Proprotein convertase subtilisin/kexin type 9 (PCSK9): A new therapeutic target].
Guijarro C; Ruilope LM
Med Clin (Barc); 2015 Jul; 145(2):67-9. PubMed ID: 26004275
[No Abstract] [Full Text] [Related]
[Next] [New Search]
